About Epinoma
Epinoma is a Healthcare company based in San Carlos (United States) founded in 2020. Limited information available. Epinoma has raised $125 thousand across 2 funding rounds from investors including seedToB, SeaX Ventures and Y Combinator. The company has 4 employees. Epinoma offers products and services including Protein Engineering Platform, Epigenetic Diagnostics, and Epigenetic Therapeutics. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is EPINOMA INC. Its competitors include Chroma Medicine, FOXO Technologies and Reaction Biology; 1 of its 3 listed competitors has raised funding.
Company details
Epinoma, established in 2020, excels in life sciences, focusing on genomic solutions, enabling technologies, technology platforms, and epigenetics. Limited information available. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters San Carlos, United States
- Employees 4
- SectorsHealthcare
- Email••••••••
- Website epinoma.com
- Social LinkedIn
- Legal Name Epinoma Inc
- Total Equity Funding$125K (USD)
in 2 rounds
- InvestorsseedToB
& 8 more
- Employee Count4
Products & Services of Epinoma
Epinoma offers a comprehensive portfolio of products and services, including Protein Engineering Platform, Epigenetic Diagnostics, and Epigenetic Therapeutics.
Platform for developing epigenetic diagnostics and therapeutics
Tools to detect diseases via methylation patterns in gene expression
Methods to modulate epigenetic sites for disease treatment
Funding Insights of Epinoma
Epinoma has successfully raised a total of $125K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $125,000
- Total Rounds 2
- First Round $125,000
(Sep 2021)
- Investors Count 9
All 2 funding rounds of Epinoma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | Seed | – | seedToB | ||
| Sep 2021 | $125,000 | Seed | – | Y Combinator | – |
9 investors in total: 4 institutional and 5 angel.
Investors in Epinoma
Epinoma has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include seedToB, SeaX Ventures and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| seaxventures.vc | ||||
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States | ||
Early-stage startups are invested in by Asymmetry Ventures fund. | asymmetry.vc | San Francisco, United States | ||
Invests in Seed and Series A AI healthcare startups with network and tactical support. | 2020 | seedtob.com | Canada | |
JG Jude Gomila | unknown_750234f473884058b | |||
GC George Church | unknown_fa02f059de984090b | |||
RW Ray Wu | unknown_ebdfcbe57831409cb | |||
EP Ethan Perlstein | Biotech innovator, angel investor, and founder of Perlara, focused on rare diseases. | unknown_9ab429a5d7a74209b | ||
MR Murray Reicher | Angel investor focusing on Indian startups, tech enthusiast | unknown_34e750b0908b494bb |
Investor details for Epinoma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Epinoma
1 people are tracked at Epinoma (1 in leadership); the tracked headcount is 4.
| Name | Role | Group |
|---|---|---|
Varun G. | CEO and Co-Founder | Leadership |
Complete people profiles for Epinoma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Epinoma
3 dated milestones of Epinoma across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Epinoma is founded.
- Funding First funding round of $125K.
- Funding Latest funding round, Seed,.
Competitors of Epinoma
Epinoma has 3 listed competitors in our database, 1 of them funded. They include Chroma Medicine, FOXO Technologies and Reaction Biology.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| chromamedicine.com | 2020 | Cambridge, United States | $135M | 122 | Epigenetic editing platform is developed for genomic medicines. | |
| foxotechnologies.com | 2020 | Minneapolis, United States | Epigenetic biomarkers are discovered and developed via AI platforms. | |||
| reactionbiology.com | 2001 | United States | 77 | In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling |
Detailed competitors of Epinoma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Epinoma (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Epinoma
Complete news archive for Epinoma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epinoma
Epinoma was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Epinoma is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Epinoma is a funded company, having raised a total of $125K across 2 funding rounds to date. The company's 1st funding round was a Seed of $125K, raised on Sep 2021.
Epinoma has 4 employees.
Epinoma, established in 2020, excels in life sciences, focusing on genomic solutions, enabling technologies, technology platforms, and epigenetics. Limited information available. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Epinoma's top competitors include Chroma Medicine, FOXO Technologies and Reaction Biology.
Epinoma offers Protein Engineering Platform, Epigenetic Diagnostics, and Epigenetic Therapeutics.
Epinoma has 9 investors. Key investors include seedToB, SeaX Ventures, Y Combinator, Asymmetry Ventures, and Jude Gomila.
Epinoma operates through Epinoma Inc.